Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemia

Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology

Roberto M. Lang, Michelle Bierig, Richard B. Devereux et al. · Journal of the American Society of Echocardiography · 2005 · 11.3K citations

Medicine, Cardiology, Clinical Cardiology +14

Congestive heart failure in patients treated with doxorubicin

Sandra M. Swain, Fredrick S. Whaley, Michael S. Ewer · Cancer · 2003 · 2.3K citations · Full text

Medicine, Oncology, Pharmacology +15

Cardiac Toxicity 4 to 20 Years After Completing Anthracycline Therapy

Laurel J. Steinherz · JAMA · 1991 · 966 citations

Medicine, Cardiology, Oncology +16

Enzymatic Defenses of the Mouse Heart Against Reactive Oxygen Metabolites

James H. Doroshow, Gershon Y. Locker, Charles E. Myers · Journal of Clinical Investigation · 1980 · 703 citations · Full text

Life Sciences, Biochemistry, Toxicology +17

The Effect of Dexrazoxane on Myocardial Injury in Doxorubicin-Treated Children with Acute Lymphoblastic Leukemia

Steven E. Lipshultz, Nader Rifai, Virginia Dalton et al. · New England Journal of Medicine · 2004 · 620 citations

Medicine, Pharmacology, Pharmacotherapy +17